Table 1.
Pediatric |
Adult |
|||
---|---|---|---|---|
PAH | Control | PAH | Control | |
Age, yr | 13.8 ± 3.2++ | 12.1 ± 4.3++ | 62.7 ± 8.8 | 57.7 ± 9.2 |
BSA, m2 | 1.26 ± 0.34++ | 1.15 ± 0.21++ | 1.74 ± 0.31 | 1.87 ± 0.25 |
Sex (%female) | 7 (70) | 6 (60) | 4 (40) | 5 (50) |
mPAP, mmHg | 45 ± 17 | 38 ± 11 | ||
PVRi, WU/m2 | 9.7 (6.1–11.3) | 8.4 (5.4–10.6) | ||
TAPSE, cm | 2.4 ± 0.4 | 2.0 ± 0.6 | ||
BNP, ng/l | 14 (14–17) | 23 (8–64) | ||
RV EDVi, ml/m2 | 106 ± 19** | 79 ± 11 | 90 ± 23* | 70 ± 13 |
RV ESVi, ml/m2 | 51 ± 15** | 33 ± 15 | 52 ± 17* | 37 ± 13 |
RV SVi, ml/m2 | 55 ± 10*+ | 46 ± 10+ | 38 ± 13 | 35 ± 5 |
RV EF, % | 52 ± 8*+ | 58 ± 4++ | 42 ± 12 | 49 ± 6 |
RV CI, l·min−1·m2 | 4.1 ± 1.2+ | 3.6 ± 0.2++ | 2.9 ± 1.0* | 2.0 ± 0.3 |
Values are means ± SD; n = 10. BNP, brain natriuretic peptide; BSA, CI, cardiac index; EDVi, end-diastolic volume index; EF, ejection fraction; ESVi, end-systolic volume index; mPAP, mean pulmonary arterial pressure; PAH, pulmonary arterial hypertension; PVRi, pulmonary vascular resistance index; RV, right ventricle; SVi, stroke volume index; TAPSE, trans-annular plane systolic excursion.
P < 0.05 and
P < 0.01 from respective control;
P < 0.05 and
P < 0.01 from respective PAH or control group.